Capital Research Global Investors Integra Lifesciences Holdings Corp Transaction History
Capital Research Global Investors
- $440 Billion
- Q1 2025
A detailed history of Capital Research Global Investors transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Capital Research Global Investors holds 825,742 shares of IART stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
825,742
Previous 1,400,559
41.04%
Holding current value
$10.7 Million
Previous $31.8 Million
42.83%
% of portfolio
0.0%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding IART
# of Institutions
241Shares Held
79.2MCall Options Held
23.3KPut Options Held
2.3K-
Black Rock Inc. New York, NY11.3MShares$146 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.52MShares$97.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.81MShares$62.6 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY4.64MShares$60.4 Million2.93% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$54.8 Million0.26% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.09B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...